BRUSSELS (Reuters) - Novavax has told the European Union it plans to begin delivering its COVID-19 vaccine to the bloc towards the end of this year, new guidance that could lead to a formal contract being signed as early as this week, an EU official told Reuters.
A deal would see Novavax supply a total of up to 200 million doses of the vaccine, providing the EU with booster shots to help contain the coronavirus and potentially guard against new variants, according to the official, who has direct knowledge of the discussions.